Related Experiment Video
Updated: Jul 5, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
EWS/FLI mediates transcriptional repression via NKX2.2 during oncogenic transformation in Ewing's sarcoma
Leah A Owen1, Ashley A Kowalewski, Stephen L Lessnick
1Department of Oncological Sciences, University of Utah, Salt Lake City, Utah, United States of America.
Abstract:
EWS/FLI is a master regulator of Ewing's sarcoma formation. Gene expression studies in A673 Ewing's sarcoma cells have demonstrated that EWS/FLI downregulates more genes than it upregulates, suggesting that EWS/FLI, and/or its targets, function as transcriptional repressors. One critical EWS/FLI target, NKX2.2, is a transcription factor that contains both transcriptional activation and transcriptional repression domains, raising the possibility that it mediates portions of the EWS/FLI transcriptional signature. We now report that microarray analysis demonstrated that the transcriptional profile of NKX2.2 consists solely of downregulated genes, and overlaps with the EWS/FLI downregulated signature, suggesting that NKX2.2 mediates oncogenic transformation via transcriptional repression. Structure-function analysis revealed that the DNA binding and repressor domains in NKX2.2 are required for oncogenesis in Ewing's sarcoma cells, while the transcriptional activation domain is completely dispensable. Furthermore, blockade of TLE or HDAC function, two protein families thought to mediate the repressive function of NKX2.2, inhibited the transformed phenotype and reversed the NKX2.2 transcriptional profile in Ewing's sarcoma cells. Whole genome localization studies (ChIP-chip) revealed that a significant portion of the NKX2.2-repressed gene expression signature was directly mediated by NKX2.2 binding. These data demonstrate that the transcriptional repressive function of NKX2.2 is necessary, and sufficient, for the oncogenic phenotype of Ewing's sarcoma, and suggest a therapeutic approach to this disease.
Insights
The transcription factor NKX2.2 drives Ewing sarcoma oncogenesis by repressing genes. Its DNA binding and repressor domains are essential, while its activation domain is not, suggesting therapeutic targeting of repression.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Ewing sarcoma is driven by the EWS/FLI oncoprotein, which primarily downregulates gene expression.
- NKX2.2, a target of EWS/FLI, possesses both activation and repression domains, suggesting it may mediate EWS/FLI's effects.
Purpose of the Study:
- To investigate the role of NKX2.2's transcriptional repressive function in Ewing sarcoma oncogenesis.
- To determine if NKX2.2 mediates the oncogenic transcriptional signature of EWS/FLI.
Main Methods:
- Microarray analysis to assess NKX2.2's transcriptional profile.
- Structure-function analysis of NKX2.2 domains in Ewing sarcoma cells.
- ChIP-chip to identify NKX2.2 genomic binding sites.
- Assays to block TLE or HDAC function.
Main Results:
- NKX2.2 solely downregulates genes, with a significant overlap with the EWS/FLI downregulated signature.
- The DNA binding and repressor domains of NKX2.2 are crucial for oncogenesis, while the activation domain is dispensable.
- Blocking TLE or HDAC function inhibited the transformed phenotype and reversed NKX2.2's transcriptional profile.
- ChIP-chip confirmed direct NKX2.2 binding at a substantial portion of repressed genes.
Conclusions:
- NKX2.2 mediates Ewing sarcoma oncogenesis through its transcriptional repressive function.
- The repressive activity of NKX2.2 is both necessary and sufficient for the transformed phenotype.
- Targeting NKX2.2's repression mechanisms offers a potential therapeutic strategy for Ewing sarcoma.
Related Concept Videos
Canonical Wnt Signaling Pathway
Master Transcription Regulators
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Methods of Nuclear Reprogramming
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

